Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases

Oncotarget

Volumn 5, Issue 12, 2014, Pages 4195-4210

  Sfaxi, Fatma ^a,b   Scamuffa, Nathalie ^a,b   Lalou, Claude ^a,b   Ma, Jia ^a,b   Metrakos, Peter ^c   Siegfried, Géraldine ^a,b   Ragg, Hermann ^d   Bikfalvi, Andreas ^a,b   Calvo, Fabien ^b   Khatib, Abdel Majid ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d BIELEFELD UNIVERSITY   (Germany)

Author keywords

Furin; Mitogenic activity; PACE4; PC5; PC7; Spn4A

Indexed keywords

FURIN; PACE4; PLATELET DERIVED GROWTH FACTOR A; PROPROTEIN CONVERTASE 5A; PROPROTEIN CONVERTASE 5B; PROPROTEIN CONVERTASE 7; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SERPIN SPN4A; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; APOP-1 PROTEIN, MOUSE; APOPTOSIS REGULATORY PROTEIN; MITOCHONDRIAL PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOSENSITIVITY; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; CT 26 CELL LINE; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FEMALE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; SECRETORY PATHWAY; SKIN TUMOR; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; ADENOCARCINOMA; COLORECTAL TUMOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY;

ADENOCARCINOMA; APOPTOSIS REGULATORY PROTEINS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HUMANS; MITOCHONDRIAL PROTEINS; NEOPLASM METASTASIS; PROPROTEIN CONVERTASES; SERPINS; TRANSFECTION;

EID: 84905089142     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1966     Document Type: Article

References (37)

1. Bassi DE, Lopez De Cicco R, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ. PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res. 2005; 65: 7310-7319.
2. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol. 2002; 3: 753-766.
3. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chrétien M, Seidah NG, Khatib AM. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest. 2003; 111: 1723-1732.
4. Siegfried G, Khatib AM, Benjannet S, Chrétien M, Seidah NG. The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. Cancer Res. 2003; 63: 1458-1463.
5. Khatib AM, Siegfried G, Prat A, Luis J, Chrétien M, Metrakos P, Seidah NG. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem. 2001; 276: 30686-30693.
6. Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, Calvo F, Seidah NG, Khatib AM. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest. 2008; 118: 352-363.
7. Khatib AM, Siegfried G, Chrétien M, Metrakos P, Seidah NG. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am J Pathol 2002; 160: 1921-1935.
8. Tzimas GN, Chevet E, Jenna S, Nguyên DT, Khatib AM, Marcus V, Zhang Y, Chrétien M, Seidah N, Metrakos P. Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases. BMC Cancer. 2005; 5: 149.
9. Jean F, Stella K, Thomas L, Liu G, Xiang Y, Reason AJ, Thomas G. alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc Natl Acad Sci U S A. 1998; 95: 7293-7298.
10. Scamuffa N, Sfaxi F, Ma J, Lalou C, Seidah N, Calvo F, Khatib AM. Prodomain of the proprotein convertase subtilisin/kexin Furin (ppFurin) protects from tumor progression and metastasis. Carcinogenesis. 2014: 35: 528-36.
11. Rockwell NC, Krysan DJ, Komiyama T, Fuller RS. Precursor processing by kex2/furin proteases. Chem Rev. 2002; 102: 4525-4548.
12. Mbikay M, Seidah N.G, Chretien M. Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J. 2001; 357: 329-342.
13. Fortenberry Y, Hwang JR, Apletalina EV, Lindberg I. Functional characterization of ProSAAS: similarities and differences with 7B2. J Biol Chem. 2002; 277: 5175-5186.
14. Cornwall GA, Cameron A, Lindberg I, Hardy DM, Cormier N, Hsia N. The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2. Endocrinology. 2003; 144: 901-908.
15. Dahlen JR, Foster DC, Kisiel W. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues. Biochem Biophys Res Commun. 1998; 244: 172-7
16. Olson ST, Swanson R, Day D, Verhamme I, Kvassman J, Shore JD. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin. Biochemistry.
17. Bernot D, Stalin J, Stocker P, Bonardo B, Scroyen I, Alessi MC, Peiretti F. Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase. J Cell Sci. 2011; 124: 1224-30.
18. Leblond J, Laprise MH, Gaudreau S, Grondin F, Kisiel W, Dubois CM. The serpin proteinase inhibitor 8: an endogenous furin inhibitor released from human platelets. Thromb Haemost. 2006; 95: 243-52.
19. Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002; 102: 4751-4804.
20. van Gent D, Sharp P, Morgan K, Kalsheker N. Serpins: structure, function and molecular evolution. Int J Biochem Cell Biol. 2003; 35: 1536-1547.
21. Krüger O, Ladewig J, Köster K, Ragg H. Widespread occurrence of serpin genes with multiple reactive centre-containing exon cassettes in insects and nematodes. Gene. 2002; 293: 97-105.
22. Brüning M, Lummer M, Bentele C, Smolenaars MM, Rodenburg KW, Ragg H. The Spn4 gene from Drosophila melanogaster is a multipurpose defence tool directed against proteases from three different peptidase families. Biochem J. 2007; 401: 325-31.
23. Oley M, Letzel MC, Ragg H. Inhibition of furin by serpin Spn4A from Drosophila melanogaster. FEBS Lett. 2004; 577: 165-169.
24. Richer MJ, Keays CA, Waterhouse J, Minhas J, Hashimoto C, Jean F. The Spn4 gene of Drosophila encodes a potent furin-directed secretory pathway serpin. Proc Natl Acad Sci U S A. 2004; 101: 10560-10565.
25. De Bie I, Savaria D, Roebroek AJ, Day R, Lazure C, Van de Ven WJ, Seidah NG. Processing specificity and biosynthesis of the Drosophila melanogaster convertases dfurin1, dfurin1-CRR, dfurin1-X, and dfurin2. J Biol Chem. 1995; 270: 1020-1028.
26. Siekhaus DE, Fuller RS. A role for amontillado, the Drosophila homolog of the neuropeptide precursor processing protease PC2, in triggering hatching behavior. J Neurosci. 1999; 19: 6942-6954.
27. Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 2000; 407: 923-926.
28. Ross J, Jiang H, Kanost MR, Wang Y. Serine proteases and their homologs in the Drosophila melanogaster genome: an initial analysis of sequence conservation and phylogenetic relationships. Gene. 2003; 304: 117-131.
29. Page RE, Klein-Szanto AJ, Litwin S, Nicolas E, Al-Jumaily R, Alexander P, Godwin AK, Ross EA, Schilder RJ, Bassi DE. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol. 2007; 29: 289-99.
30. Buck E, Mulvihill M. Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer. Expert Opin Investig Drugs. 2011; 20: 605-621.
31. Culouscou JM, Remacle-Bonnet M, Garrouste F, Marvaldi J, Pommier G. Simultaneous production of IGF-I and EGF competing growth factors by HT-29 human colon cancer line. Int J Cancer. 1987; 40: 646-652.
32. Lapierre M, Siegfried G, Scamuffa N, Bontemps Y, Calvo F, Seidah NG, Khatib AM. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. Cancer Res. 2007; 67: 9030-9034.
33. Kang T, Nagase H, Pei D. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res. 2002; 62: 675-681.
34. Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol Carcinog. 2005 44: 151-61.
35. Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, et al. Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer. Mol Ther. 2012; 20: 679-686.
36. Gu M, Gordon VM, Fitzgerald DJ, Leppla SH. Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cells. Infect Immun. 1996; 64: 524-527.
37. Lalou C, Scamuffa N, Mourah S, Plassa F, Podgorniak MP, Soufir N, Dumaz N, Calvo F, Basset-Seguin N, Khatib AM. Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes. PLoS One. 2010; 5: e9992.